High-Frequency Oscillations on Interictal Epileptiform Discharges in Routinely Acquired Scalp EEG: Can It Be Used as

Hanan El Shakankiry1, Susan T Arnold1

  • 1UT Southwestern Medical School, Children's Health, Dallas, TX, United States.

Insights

High-frequency oscillations (HFOs) accompanying epileptiform discharges (EDs) in pediatric EEG predict a higher risk of seizure recurrence. This finding aids in guiding anti-seizure medication (ASM) decisions for children with epilepsy.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neurophysiology

Background:

  • Optimizing epilepsy management in children remains challenging due to unclear consensus on treating epileptiform discharges (EDs) after a first unprovoked seizure.
  • Identifying reliable markers on scalp electroencephalogram (EEG) to guide treatment decisions for pathological EEG discharges is crucial.

Purpose of the Study:

  • To determine if the presence of ripples/high-frequency oscillations (HFOs) alongside interictal EDs (IEDs) in routine scalp EEG predicts seizure recurrence in children.
  • To evaluate HFOs as a potential prognostic marker in pediatric epilepsy.

Main Methods:

  • Retrospective analysis of 100 children with new-onset seizures and focal EDs on EEG, who were not on anti-seizure medication (ASM).
  • EEGs were acquired at 500 Hz and analyzed blinded to patient data, with HFOs visually identified.
  • Inter-rater reliability for HFO identification was assessed.

Main Results:

  • High-frequency oscillations (HFOs) were identified in 19% of patients, with higher prevalence in younger children and association with spikes and higher amplitude EDs.
  • Patients with HFOs showed a significantly higher likelihood of seizure recurrence within one year and continued seizures after two years.
  • No significant difference was observed in the decision to continue ASM after two years between groups.

Conclusions:

  • Analysis of HFOs in routine EEG can enhance diagnostic yield and inform decisions regarding the initiation or discontinuation of ASM.
  • Identifying HFOs may help pinpoint pathological discharges with adverse effects on brain development, potentially establishing new therapeutic targets in epilepsy management.
Abstract